Great Tree Pharmacy Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Ming Long Zheng

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	13.3%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	4.4yrs

Recente managementupdates

Recent updates

There Are Reasons To Feel Uneasy About Great Tree Pharmacy's (GTSM:6469) Returns On Capital

Mar 24

Is Great Tree Pharmacy (GTSM:6469) A Risky Investment?

Mar 03

Is Great Tree Pharmacy Co., Ltd.'s (GTSM:6469) Stock's Recent Performance A Reflection Of Its Financial Health?

Feb 09

Great Tree Pharmacy's (GTSM:6469) Earnings Are Growing But Is There More To The Story?

Jan 19

Did You Miss Great Tree Pharmacy's (GTSM:6469) 71% Share Price Gain?

Dec 28

Should We Be Excited About The Trends Of Returns At Great Tree Pharmacy (GTSM:6469)?

Dec 09

CEO

Ming Long Zheng

no data

Tenure

Mr. Ming Long Zheng is Chairman, Manager, CEO & President of Great Tree Pharmacy Co., Ltd. He was CEO & President of Great Tree Pharmacy Co., Ltd.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Shan-Feng Lu	Director & Deputy GM	3.3yrs	NT$1.94m	1.13% NT$ 253.1m
Ming Long Zheng	Chairman	no data	geen gegevens	13.29% NT$ 3.0b
Shih-Wei Yeh	Assistant Manager of Product Purchase & Marketing Department and Director	no data	geen gegevens	0.59% NT$ 132.6m
Tian-Dao Liu	Independent Director	10.2yrs	NT$696.00k	geen gegevens
Li-Ping Shen	Director	10.5yrs	NT$671.00k	0.10% NT$ 22.4m
Hung-Yi Chen	Director	4.4yrs	NT$675.00k	geen gegevens
Hsing-Wen Wang	Independent Director	7.4yrs	NT$651.00k	geen gegevens
Dai-Huang Kuo	Independent Director	4.4yrs	NT$651.00k	0.064% NT$ 14.3m
Min-Hsiung Pan	Independent Director	1.5yrs	geen gegevens	geen gegevens

4.4yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van 6469 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.4 jaar).

Great Tree Pharmacy Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Less than half of directors are independent

Great Tree Pharmacy Co., Ltd. Announces Convener of Audit Committee Changes

Great Tree Pharmacy Co., Ltd. Appoints Min-Hsiung Pan as Member of the Audit Committee and the Remuneration Committee

Great Tree Pharmacy Co., Ltd. Elects Min-Hsiung Pan as Independent Director

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: NT$1.27 (vs NT$1.26 in 3Q 2023)

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: NT$1.29 (vs NT$1.29 in 2Q 2023)

Great Tree Pharmacy Co., Ltd. to Report Q2, 2024 Results on Aug 09, 2024

Upcoming dividend of NT$3.60 per share

Dividend of NT$3.60 announced

Great Tree Pharmacy Co., Ltd. Announces Cash Dividend , Payable on July 31, 2024

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 13%

Great Tree Pharmacy Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Less than half of directors are independent

Full year 2023 earnings: EPS and revenues miss analyst expectations

Great Tree Pharmacy Co., Ltd. announced a financing transaction

New minor risk - Shareholder dilution

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

New major risk - Earnings quality

Great Tree Pharmacy Co., Ltd. Announces Convener of Audit Committee Changes

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 18%

Upcoming dividend of NT$4.70 per share at 1.3% yield

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Great Tree Pharmacy Co., Ltd. Announces Cash Dividend for the Year 2022, Payable on July 28, 2023

Great Tree Pharmacy Co., Ltd. Appoints Min-Hsiung Pan as Member of the Audit Committee and the Remuneration Committee

Great Tree Pharmacy Co., Ltd. Elects Min-Hsiung Pan as Independent Director

Now 23% undervalued

Full year 2022 earnings: EPS misses analyst expectations

Price target increased by 7.6% to NT$324

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Great Tree Pharmacy Co., Ltd. announced that it has received TWD 220 million in funding from Sugi Holdings Co.,Ltd.

Great Tree Pharmacy Co., Ltd. announced that it expects to receive funding from Sugi Holdings Co.,Ltd.

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Upcoming dividend of NT$2.57 per share

Great Tree Pharmacy Co., Ltd. Announces Cash Dividend, Payable on July 21, 2022

Investor sentiment improved over the past week

Less than half of directors are independent

First quarter 2022 earnings released: EPS: NT$1.67 (vs NT$1.04 in 1Q 2021)

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Great Tree Pharmacy Co., Ltd. Approves Dividend Distribution for the Year Ended December 31, 2021

Great Tree Pharmacy Co., Ltd., Annual General Meeting, May 31, 2022

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$1.51 (vs NT$0.66 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS NT$2.20 (vs NT$0.86 in 2Q 2020)

Investor sentiment improved over the past week

Upcoming dividend of NT$0.99 per share

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$1.34 (vs NT$0.92 in 1Q 2020)

Investor sentiment improved over the past week

There Are Reasons To Feel Uneasy About Great Tree Pharmacy's (GTSM:6469) Returns On Capital

Great Tree Pharmacy Co., Ltd. Approves Dividend Distribution

Great Tree Pharmacy Co., Ltd., Annual General Meeting, Jun 24, 2021

Full year 2020 earnings released: EPS NT$3.73 (vs NT$2.77 in FY 2019)

New 90-day high: NT$101

Is Great Tree Pharmacy (GTSM:6469) A Risky Investment?

Is Great Tree Pharmacy Co., Ltd.'s (GTSM:6469) Stock's Recent Performance A Reflection Of Its Financial Health?

Great Tree Pharmacy's (GTSM:6469) Earnings Are Growing But Is There More To The Story?

Did You Miss Great Tree Pharmacy's (GTSM:6469) 71% Share Price Gain?

Should We Be Excited About The Trends Of Returns At Great Tree Pharmacy (GTSM:6469)?

New 90-day high: NT$100.00

Third quarter 2020 earnings released: EPS NT$0.86

New 90-day high - NT$94.50

First half earnings released

CEO